These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11788694)

  • 21. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel.
    Semba CP; Murphy TP; Bakal CW; Calis KA; Matalon TA
    J Vasc Interv Radiol; 2000 Feb; 11(2 Pt 1):149-61. PubMed ID: 10716384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
    Raabe RD
    J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
    Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
    Hull JE; Hull MK; Urso JA
    J Vasc Interv Radiol; 2004 Jun; 15(6):557-64. PubMed ID: 15178715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.
    Razavi MK; Wong H; Kee ST; Sze DY; Semba CP; Dake MD
    J Endovasc Ther; 2002 Oct; 9(5):593-8. PubMed ID: 12431142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
    Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
    Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
    Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
    J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simple and effective rt-PA thrombolysis design].
    Cejna M; Salomonowitz E; Wohlschlager H; Zwrtek K; Böck R
    Rofo; 1998 Nov; 169(5):521-5. PubMed ID: 9849604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombolysis of acute arterial occlusion with rt PA].
    Kurtoğlu M; Granit V; Necefli A; Kurtoğlu M; Güloğlu R
    Ulus Travma Derg; 2001 Jul; 7(3):158-62. PubMed ID: 11705216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA).
    Hess H; Mietaschk A; von Bilderling P; Neller P
    Eur J Vasc Endovasc Surg; 1996 Jul; 12(1):97-104. PubMed ID: 8696906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase.
    Gong M; He X; Song J; Zhao B; Shi W; Chen G; Gu J
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1333-1339. PubMed ID: 29768935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion.
    Shortell CK; Queiroz R; Johansson M; Waldman D; Illig KA; Ouriel K; Green RM
    J Vasc Surg; 2001 Nov; 34(5):854-9. PubMed ID: 11700486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulsed spray lysis with reteplase in peripheral arterial occlusions--technique and initial results].
    Tepe G; Luz O; Hahn U; Pereira P; König C; Ziemer G; Claussen CD; Duda SH
    Rofo; 2000 Sep; 172(9):780-4. PubMed ID: 11079093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions.
    Davidian MM; Powell A; Benenati JF; Katzen BT; Becker GJ; Zemel G
    J Vasc Interv Radiol; 2000 Mar; 11(3):289-94. PubMed ID: 10735421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
    Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
    Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity.
    Weaver FA; Comerota AJ; Youngblood M; Froehlich J; Hosking JD; Papanicolaou G
    J Vasc Surg; 1996 Oct; 24(4):513-21; discussion 521-3. PubMed ID: 8911400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose thrombolysis for thromboembolic lower extremity arterial occlusions is effective without major hemorrhagic complications.
    Ebben HP; Nederhoed JH; Lely RJ; Meijerink MR; van der Meijs BB; Wisselink W; Yeung KK; Hoksbergen AW
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):551-8. PubMed ID: 25108710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.